Parkinson's Disease: Comprehensive Symptom Overview
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor manifestations.
Cardinal Motor Symptoms (TRAP)
| Symptom | Description |
| Tremor at rest | 4–6 Hz "pill-rolling" tremor; starts asymmetrically (hand/jaw/foot); decreases with action, disappears in sleep. |
| Rigidity | Lead-pipe (uniform) or cogwheel (tremor-superimposed) resistance to passive movement; causes pain, reduced range. |
| Akinesia/Bradykinesia | Slowness, reduced amplitude, difficulty initiating movement; micrographia, hypomimia, shuffling gait. |
| Postural instability | Impaired righting reflexes; retropulsion; falls (late feature; early falls suggest atypical parkinsonism). |
Other Motor Features
- Freezing of gait (FOG): "Feet glued to floor" — narrow spaces, turns, dual-tasking.
- Dystonia: Sustained muscle contractions (e.g., foot inversion, toe curling), often off-period or drug-induced.
- Speech changes: Hypophonia, monotone, festinating (accelerating), dysarthria.
- Dysphagia: Silent aspiration risk; weight loss, pneumonia.
- Seborrheic dermatitis: Oily, flaky skin (face/scalp).
Non-Motor Symptoms (Often Precede Motor by Years)
- Autonomic: Constipation, orthostatic hypotension, urinary urgency/frequency, sexual dysfunction, hyperhidrosis.
- Neuropsychiatric: Depression (40–50%), anxiety, apathy, psychosis (hallucinations — often drug-related), impulse control disorders (dopamine agonists).
- Cognitive: Executive dysfunction → dementia (PDD) in ~80% at 20 years.
- Sleep: REM sleep behavior disorder (RBD — prodromal), insomnia, excessive daytime sleepiness, restless legs.
- Sensory: Hyposmia (early), pain (musculoskeletal, neuropathic, central).
Progression and Heterogeneity
- Hoehn & Yahr stages 1–5 (unilateral → wheelchair/bedbound).
- MDS-UPDRS: Comprehensive rating scale (Parts I–IV).
- Subtypes: Tremor-dominant (slower progression), PIGD (postural instability/gait difficulty — faster decline, more cognitive impairment).
Management
- Levodopa (gold standard), dopamine agonists, MAO-B/COMT inhibitors, amantadine.
- DBS (subthalamic nucleus or GPi) for motor fluctuations/dyskinesias refractory to meds.
- Exercise (aerobic, resistance, balance), PT/OT/SLT, multidisciplinary care.
Early diagnosis and holistic management optimize quality of life.
Neurological Disorders - Related Articles